within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A16A_OtherAlimentaryTractAndMetabolismProducts.A16AB22_AvalglucosidaseAlfa;
model AvalglucosidaseAlfa 
   extends Pharmacolibrary.Drugs.ATC.A.A16AB22;

  annotation(Documentation(
    info ="<html><body><p>Avalglucosidase alfa is a recombinant human acid alpha-glucosidase enzyme indicated for long-term enzyme replacement therapy in patients with Pompe disease (acid alpha-glucosidase deficiency). It is approved for use in the treatment of late-onset Pompe disease.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult subjects with late-onset Pompe disease after intravenous administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end AvalglucosidaseAlfa;
